共 9 条
[1]
Bcl2 initiates a new category of oncogenes regulators of cell death. Korsmeyer B S. Blood . 1992
[2]
Identification of intronic point mutations as an alternation mechanism for p53 inactivation in lung cancer. Takahashi T,Amico D D,Chiba I,et al. The Journal of Clinical Investigation . 1990
[3]
p53 mutaions in human cancers. Houstein M,Sidransky D,Vogelstein B,et al. Science . 1991
[4]
Aberations of the p53 tumor suppressor Gene in human Non-Small cell carcinomas of the lung. Kishimoto Y,Murrakami Y,Shiraishi M,et al. Cancer Research . 1992
[5]
Distinctive chromosomal abnormalities in histologic subtypes of nonnodgkin ’ s lymphoma. Yanis J J,Oken M M,Kaplan M F,et al. The New England Journal of Medicine . 1982
[6]
C-myc and bcl2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Ryan J J,Prochownik E,Gottlieb CA,et al. Proceedings of the National Academy of Sciences of the United States of America . 1994
[7]
Activation of cyclin A-dependent protein kinases during apotosis. Meikrantz W,Gisselbrecht S,Tam S W,et al. Proceedings of the National Academy of Sciences of the United States of America . 1994
[8]
Deregulated bcl2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. Nunez G,Hockenbery D,Mckearan J R,et al. J Immunol . 1990
[9]
Cell death studies yield cancer clues. Marx J. Science . 1993